5,000-Patient study to unlock immunotherapy secrets for lymph node cancer

This study looks at how well immunotherapy shrinks tumors and lymph node metastases in 5,000 people with various cancers. Researchers will track changes in tumor and lymph node size after treatment and explore factors like beta-blocker use that might affect results. The goal is to help doctors personalize immunotherapy for patients with lymph node spread.